Pfizer Should Face Label Suit, Robitussin Buyers Say
Pharmaceutical giant Pfizer should have to face claims that it's deceitful about the "maximum strength" of its cough medicine Robitussin, a proposed class of consumers told an Illinois federal judge on...To view the full article, register now.
Already a subscriber? Click here to view full article